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Abstract
Most studies of c-Jun N-terminal Kinase (JNK) activation in retinal tissue were done in the context of neurodegeneration. In
this study, we investigated the behavior of JNK during mitosis of progenitor cells in the retina of newborn rats. Retinal
explants from newborn rats were kept in vitro for 3 hours and under distinct treatments. Sections of retinal explants or
freshly fixed retinal tissue were used to detect JNK phosphorylation by immunohistochemistry, and were examined through
both fluorescence and confocal microscopy. Mitotic cells were identified by chromatin morphology, histone-H3
phosphorylation, and location in the retinal tissue. The subcellular localization of proteins was analyzed by double staining
with both a DNA marker and an antibody to each protein. Phosphorylation of JNK was also examined by western blot. The
results showed that in the retina of newborn rats (P1), JNK is phosphorylated during mitosis of progenitor cells, mainly
during the early stages of mitosis. JNK1 and/or JNK2 were preferentially phosphorylated in mitotic cells. Inhibition of JNK
induced cell cycle arrest, specifically in mitosis. Treatment with the JNK inhibitor decreased the number of cells in anaphase,
but did not alter the number of cells in either prophase/prometaphase or metaphase. Moreover, cells with aberrant
chromatin morphology were found after treatment with the JNK inhibitor. The data show, for the first time, that JNK is
activated in mitotic progenitor cells of developing retinal tissue, suggesting a new role of JNK in the control of progenitor
cell proliferation in the retina.
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Introduction
The retina is part of the central nervous system and is widely
used as a model to study mechanisms of neurogenesis [1], due to
knowledge of the spatio-temporal development of various retinal
cell types. In newborn rats, the innermost (basal) cell layer is the
ganglion cell layer (GCL) that contains only relatively differenti-
ated ganglion cells [2], because displaced amacrine cells migrate
postnatally into the GCL [3]. Further towards apical retina, there
is an immature inner nuclear layer (INLi), followed by the
proliferative neuroblastic layer (NBL). The NBL of neonatal rats
contains both proliferating progenitor and postmitotic cells,
including early developing horizontal cells [4]. The cell cycle in
the proliferative zone of the retina, similar to other parts of the
CNS, is tightly controlled and proceeds in synchrony with
interkinetic migration of the progenitor cell nuclei along the
depth of the NBL [5]. The phases of the cell cycle are easily
identified in retinal progenitor cells, due to interkinetic nuclear
migration [6]. DNA synthesis occurs in the inner side of the NBL,
while mitosis is restricted to the outermost side of the NBL, as
shown by immunohistochemical detection of phosphorylated
histone-H3, which associates with condensing chromosomes of
dividing cells [7]. The spatial segregation of the phases of the cell
cycle along the interkinetic migration pathway facilitates experi-
mental studies of cell proliferation in the retina. Nonetheless, the
intracellular mechanisms that control phase transitions during the
cell cycle are still poorly understood.
Mitogen-activated protein kinases (MAPK) are a group of
enzymes that includes the extracellular-activated kinases (ERK),
and the stress-activated protein kinases c-Jun N-terminal kinase
(JNK) and p38. MAPK cascades are organized as a core signaling
module consisting of three protein kinases: a MAP kinase kinase
kinase (MKKK), a MAP kinase kinase (MKK), and a MAP kinase
[8]. The JNK pathway is predominantly activated by stress stimuli
such as cytokines, mitogens, osmotic stress and ultraviolet
irradiation [9–12]. Ten JNK isoforms arise from alternative
splicing of messenger RNA transcripts derived from three genes:
jnk1, jnk2 and jnk3 [13]. JNK1 and JNK2 are ubiquitously
expressed, while JNK3 is restricted to brain, heart and testis
[10,14]. Targeted gene disruption of each JNK has also disclosed
differing functions of JNK1, JNK2 and JNK3 in distinct cell types,
relative to gene expression, apoptosis, proliferation and other
critical physiological responses [15–19]. While JNK1 and JNK2
are involved in the control of cell proliferation [20–24], JNK3 is
important in the induction of neuronal cell death [15,18,19]. JNK
is activated through phosphorylation of both residues Threonine-
183 and Tyrosine-185, by the dual specificity enzymes MKK4 and
MKK7 [25]. JNK can phosphorylate a variety of nuclear and
cytoplasmic substrates. The major nuclear targets of JNK are
transcription factors, in particular c-Jun, which is phosphorylated
at both serine residues 63 and 73 [13,26,27]. In addition to
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substrates such as cytoskeletal proteins [28], MAP-2 [29] and
proteins of the Bcl-2 family such as Bim [30].
Although classically described as a kinase responsive to cellular
stress and implicated in induction of cell death, especially in the
central nervous system [15,18,31,32], several studies have
demonstrated that the activity of JNK is also involved in cell
survival and control of the cell cycle [16,33,34]. The data suggest
that the JNK signaling pathway may be involved in controlling the
M-phase of the cell cycle [35–40]. Most studies, however, were
done in either tumor cell lines [20–22,36–41] or dissociated cells
[23,24,35,42], and little is known of the role of this enzyme in cell
proliferation in the central nervous system [43–45].
We use explants taken from retinal tissue of newborn rats to
study mechanisms of cell proliferation in the developing central
nervous system [4]. This preparation is advantageous because the
retina of newborn rats differentiates in vitro in a similar rate as the
retina in situ, maintains the structure of the tissue, contains cells at
various stages of development, which can be easily recognized
both by the position of their nuclei along the thickness of the retina
and with immunohistochemical techniques and, finally, is easily
amenable to pharmacological approaches [4,46]. In the present
study, we investigated the behavior of JNK during proliferation of
progenitor cells in developing retinal tissue.
Materials and Methods
All procedures complied with the Guidelines for the Care and
Use of Laboratory Animals, from the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research, and were
approved by the Committee for the Use of Experimental Animals
of the Institute of Biophysics (CAUAP/IBCCF/UFRJ # 046-09-
2004).
Materials
Dulbecco’s Modified Eagle Medium (DMEM), Fetal Calf Serum
(FCS)and gentamicinwerefromGibco.Glutamineandhorseradish
peroxidase-conjugated anti-rabbit secondary antibody were from
Sigma. SP600125 was from Tocris Bioscience. Antibodies to
phospho-JNK (#9251) and phospho-histone-H3 (#9706) were
from Cell Signaling Technology. Antibody to c-tubulin (#ab11316)
was from Abcam. Antibodies to phospho-JNK1/2 (#07-175) and
JNK3 (#05-893) were from Upstate Biotechnology.
Tissue Culture
Lister hooded rats at postnatal day 1 (P1), were killed painlessly by
instantaneous decapitation and retinal explants were prepared as
described previously [47,48]. The neural retina was carefully dissected
out of the eyeballs free of pigment epithelium with fine forceps. At least
five fragments of about 1 mm
2(explants) were cut and placed in 25 ml
tight-lidded Erlenmeyer flasks containing 5 ml DMEM and 5% FCS,
2m Mg l u t a m i n ea n d1 0mg/ml gentamicin. Free-floating explants
were cultured for 3 h at 37uC in a 5% CO2 atmosphere, in an orbital
shaker at 70–80 rpm. Drugs (20 mM SP600125, 1 mM taxol) were
added to the medium at the beginning of the incubation period. At the
end of each experiment, the explants were fixed by immersion with
4% paraformaldehyde in phosphate buffer 0.1 M, pH 7.3, for at least
2 h, followed by cryoprotection in phosphate-buffered sucrose
solutions (30%). The explants were oriented for transverse sections,
and cut at 10 mm thickness in a cryostat.
For analysis in situ rats were killed by instantaneous decapita-
tion, the eyeballs were removed and fixed immediately in 4%
paraformaldehyde in 0.1 M phosphate buffer overnight, cryopro-
tected, and frozen sections were cut as above.
Immunohistochemistry
Immunohistochemistry was done according to manufacturer’s
instructions. For antibody against phospho-histone-H3, antigen
retrieval was carried out in citrate buffer pH 6. Sections of retinal
explants were incubated with 0.5% Triton X- 100 in phosphate
buffered-saline (PBS) pH 7.4, for 15 min, washed and incubated
with 1% BSA in PBS for 30 min. Then, the sections were
incubated overnight at 37uC with antibodies against phospho-JNK
(1:400), phospho-histone-H3 (1:100), phospho-JNK1/2 (1:100),
JNK3 (1:100) or c-tubulin (1:100). Then, the sections were
incubated with the appropriate secondary antibodies for 1 h at
37uC (HRP-ABC kit - Vector) and developed with tyramide-Cy3.
For double-labeling with phospho-histone-H3 or c-tubulin,
secondary antibody anti-mouse IgG conjugated with fluorochrome
488 was used (488 DyLigth – Jackson Immuno Research). The
chromosomal DNA was stained with DAPI (1 mg/ml) or Topro-3
(1 mM; Invitrogen). For control of the phosphorylated epitope,
some sections were treated with 10 U of calf intestine alkaline
phosphatase in reaction buffer for 1 h at 37uC, prior to
immunohistochemistry.
Microscopy and cell counts
All images were made using an LSM510 confocal microscope
coupled with an Zeiss Axiovert 200 M. Sections were also
examined in a Zeiss Axiophot fluorescence microscope. Cells in
M-phase were recognized by their location near the external
limiting membrane of the retina, the morphology of the chromatin
and also by the specific marker phospho-histone-H3. Counts were
made at 10006magnification, under oil immersion, in at least 3
distinct explants from each group, and data were pooled from at
least 3 independent experiments. The percentage of cells stained
for phospho-JNK was calculated among phospho-histone-H3
positive cells. For the analysis of phospho-JNK or phospho-
histone-H3 along the mitotic stratum of the retina, labeled cells
were counted and estimated per 100 mm of linear extent parallel to
the retinal external surface [49]. For the analysis of phospho-JNK
labeling in different mitotic stages, mitotic profiles were identified
as either prophase/prometaphase, metaphase or anaphase, by the
morphology of chromosomes stained with DAPI, then scored for
phospho-JNK immunolabeling as either heavily or poorly labeled,
or unlabeled. The percentages of either prophases/prometaphas-
es, metaphases or anaphases were calculated among total mitotic
profiles. In all experiments, at least 250 profiles were scored from
each experimental group from at least three experiments [49].
Statistical analyses were done using one-way ANOVA, followed by
Bonferroni’s post-test to compare mean values between pairs of
groups, or Student’s t-test, as appropriate.
Western Blotting
Total protein extracted from the retinal explants were separated
by 12.5% SDS-PAGE, transferred onto nitrocellulose membrane,
and probed with the same antibodies to phospho-JNK and
phospho-histone-H3 used for immunohistochemistry, followed by
a horseradish peroxidase-conjugated secondary antibody, and
visualized using ECL-plus detection reagent (Amersham). The
membranes were reblotted with a polyclonal antibody to b-actin
(Abcam), as a loading control.
Results
JNK is phosphorylated during mitosis of retinal
progenitor cells
We first examined the phosphorylation of JNK in retinal
explants of newborn rats (postnatal day 1 – P1) maintained in vitro
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phospho-histone-H3 antibodies. Immunohistochemical analysis of
retinal sections showed that cells in the outer margin of the retinal
tissue, where cells undergo mitosis, are double stained with
antibodies against both phosphorylated proteins (fig. 1A ). This
suggests that JNK is phosphorylated during mitosis of retinal
progenitor cells. In addition, phospho-JNK staining was also
detected in the GCL (data not shown).
We then examined the subcellular localization of phosphory-
lated JNK. Partial overlap was detected between phospho-JNK
and either the DNA marker or phospho-histone-H3 staining (fig. 1
C). These data suggest that JNK is activated in the cell body
during mitosis of progenitor cells in developing retina.
Because JNK phosphorylation can be induced by cellular stress,
we examined the phosphorylation of JNK in freshly fixed retinal
tissue from rats at embryonic day 14 (E14), 18 (E18), 21 (E21) and
at postnatal day 1 (P1), by double staining with the phospho-JNK
and phospho-histone-H3 antibodies. Cells in the outer margin of
the retinal tissue were double stained with antibodies against both
phosphorylated proteins only at E21 and P1 (fig. S1 C and D).
The staining at E21 was lighter than at P1. In addition, little
overlap was detected between phospho-JNK and either the DNA
marker or phospho-histone-H3 staining at E21 (fig. S1 C). These
data suggest that JNK is activated in the cellular process during
mitosis of progenitor cells in developing retina at E21. We found
no cell stained for phospho-JNK in the mitotic stratum in the outer
margin of the neuroblastic layer, nor were there any cells double
stained for phospho-JNK and phospho-histone-H3 in rats at E14
and E18 (fig. S1 A and B). Staining was detected in the GCL at all
ages analyzed (data not shown). In addition, we examined whether
JNK is phosphorylated in the rat cerebral cortex, but no labeled
cells were found in sections from P7 rat brains (data not shown).
These data suggest that JNK is phosphorylated during mitosis of
progenitor cells in the retina of rat only at E21 and P1.
To confirm that JNK is phosphorylated during mitosis, retinal
explants were maintained in vitro for 3 hours in the presence of
taxol that induces an arrest of the cell cycle in mitosis due to
inhibition of microtubule depolymerization [50]. Treatment with
taxol led to an increase in the number of phospho-JNK positive
cells in the mitotic stratum, from a mean6S.E.M. of 2.8360.25 to
14.2860.85 cells per 100 mm of linear extension along the outer
margin of the retina (fig. 1Band D). Similarly, the number of
phospho-histone-H3 positive cells increased from 3.8260.36 to
15.3261.50 cells per 100 mm, as expected (fig. 1Band D). Similar
results were seen after staining with an antibody for total JNK
(data not shown). In control conditions, 96.8%61.3 of the cells
stained for phospho-histone-H3 were also stained for phospho-
JNK, and a similar proportion (98.0%60.4) was observed in the
retina treated with taxol (fig. 1E ). These results confirm that JNK
is phosphorylated during mitosis of retinal progenitor cells in the
newborn rat.
JNK1 and/or JNK2 are preferentially phosphorylated
during mitosis of retinal progenitor cells
We examined the expression and phosphorylation of the various
isoforms of JNK in retinal explants maintained in vitro for 3 hours,
either in the absence or presence of taxol. Sections of retinal
explants were double stained with an antibody that recognizes
only the JNK3 isoform and with the antibody to phospho-histone-
H3. We found no cell stained for JNK3 in the mitotic stratum in
the outer margin of NBL, nor was there any cell double stained for
JNK3 and phospho-histone-H3 (fig. 2Aand B). JNK3 positive
cells were found only in the GCL, in the immature inner nuclear
layer and in scattered profiles within the NBL, possibly horizontal
cells, as shown by DAPI staining (fig. 2Aand B). Treatment with
taxol did not alter JNK3 staining (fig. 2B ), whereas the number of
cells stained for phospho-histone-H3 increased (fig. 2B ), as
expected. These data suggest that JNK3 is not expressed during
mitosis of retinal progenitor cells.
We next used an antibody that recognizes both phosphorylated
isoforms JNK1 and JNK2. We found cells double stained for
phospho-JNK1/2 and phospho-histone-H3 in the mitotic stratum
(fig. 3A ). In addition, staining was also detected in the GCL (fig. 3
A). The pattern of staining for phospho-JNK1/2 (fig. 3A ) was
similar to the staining with the antibody that recognizes all three
phosphorylated isoforms of JNK (fig. 1A ). Treatment with taxol
increased the number of cells double stained for phospho-JNK1/2
and phospho-histone-H3 in the mitotic stratum, but did not alter
the staining for phospho-JNK1/2 in other cells (fig. 3B ). Although
treatment with taxol changed the subcellular localization of
phospho-JNK1/2 (fig. 3B ), it did not change the pattern of
staining with the antibody that recognizes all three phosphorylated
isoforms of JNK (fig. 1B ). Thus, we could not confirm the change
in subcellular localization of JNK. However, it is clear that
treatment with taxol led to an increase in the number of mitotic
cells stained for phospho-JNK1/2. These data suggest that JNK1
and/or JNK2 are phosphorylated during mitosis of retinal
progenitor cells.
In an attempt to differentiate which isoform is phosphorylated
during mitosis, we examined western blots of phospho-JNK from
total protein extracts of retinal explants maintained in vitro for
3 hours. Western blot allows the distinction between the isoforms
JNK1 (46 kDa) and JNK2 (55 kDa) [9,11,51]. Treatment with
taxol increased by approximately 24% the amount of phosphor-
ylated JNK2, but did not alter the amount of phosphorylated
JNK1 (fig. 3Cand D). Since phosphorylated JNK1 and/or JNK2
were increased only in mitotic cells (fig. 3B ), and there was no
apparent expression of JNK3 nor changes in the phosphorylation
of JNK in other cells, the change in phosphorylation of JNK in
western blots that follows treatment with taxol is most likely
restricted to the mitotic cells. As a control that taxol arrested the
proliferating cells in mitosis, treatment with taxol increased the
phosphorylation of histone-H3, as expected (fig. 3C ). These data
suggest that isoform JNK2 could be preferentially phosphorylated
during mitosis of progenitor cells in developing retina.
JNK is preferentially phosphorylated during early stages
of mitosis in retinal progenitor cells
Microscopic examination of chromatin morphology with the
use of the DNA marker DAPI helps to distinguish among stages of
the M-phase: in prophase/prometaphase, chromosomes are
condensed and spread throughout the cell body; in metaphase,
the condensed chromosomes are clearly aligned at the metaphase
plate; and in anaphase, symmetrically diverging chromosomes are
easily detected. We examined the phosphorylation of JNK in
distinct mitotic stages in sections of retinal explants double stained
with an antibody against to phospho-JNK and counterstained with
DAPI. Approximately 80% of the prophase/prometaphase plus
metaphase profiles were heavily stained for phospho-JNK (fig. 4
A–D and G). In contrast, almost all cells in anaphase were either
unlabeled (fig. 4Fand G) or poorly labeled (fig. 4Eand G). These
data showed that JNK is preferentially phosphorylated during
early stages of mitosis in retinal progenitor cells.
Inhibition of JNK induces mitotic arrest
The phosphorylation of JNK in early stages of the M-phase
suggested that activation of JNK might be important to mitotic
progression in retinal progenitor cells. To test this hypothesis, we
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or presence of SP600125 (20 mM), an inhibitor of JNK activity,
which does not prevent the phosphorylation of the enzyme [52].
The inhibitor of JNK induced an accumulation of phospho-
histone-H3 positive cells in the mitotic stratum, from 3.8260.36 to
6.6760.27 cells per 100 mm of linear extension along the outer
margin of the retina (fig. 5A –C). Similarly, there was an
accumulation of phospho-JNK positive cells in the mitotic stratum
from 2.8360.25 to 6.7360.79 cells (fig. 5Aand B). Almost all
cells positive for phospho-histone-H3 were also positive for
phospho-JNK (fig. 5Aand B). These data suggest that inhibition
of JNK induces an accumulation of mitotic cells in the mitotic
stratum in developing retinal tissue.
We next examined chromosome morphology in the mitotic
cells. Following treatment with the JNK inhibitor, condensed
chromosomes seemed less orderly organized than in control retinal
Figure 1. JNK is phosphorylated during mitosis of retinal progenitor cells. (A, B) Representative confocal photomicrographs of
immunohistochemistry for phospho-JNK (red) and phospho-histone-H3 (green) in sections of retinal tissue maintained for 3 hours in vitro either in
absence (A - CTR) or presence of taxol (B - TAX) showing the NBL. The sections were counterstained with DAPI (blue). Arrows indicate examples of
cells double stained for phospho-JNK and phospho-histone-H3. Scale bar: 20 mm. (C) Higher magnification of mitotic cell showing the subcellular
localization of phospho-JNK (red), phospho-histone-H3 (green), and DAPI (blue). Scale bar: 10 mm. (D) Numbers of phospho-JNK or phospho-histone-
H3 stained cells per 100 mm of linear extent parallel to the retinal surface, along the mitotic stratum of retinal explants maintained in vitro for 3 hours,
either in the absence (CTR) or presence of taxol (TAX). (E) Percentage of cells stained for phospho-JNK among all cells immunolabeled for phospho-
histone-H3 in the mitotic stratum. Data are means6S.E.M. from three independent experiments. CTR - control; TAX - taxol; NBL - neuroblastic layer;
*** P,0.001 versus CTR.
doi:10.1371/journal.pone.0034483.g001
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cases, the chromosomes were arranged in a doughnut-like shape.
All such profiles were scored as aberrant (fig. 5D –F - arrows).
Nevertheless, in most cases, chromosomes in the prophase/
prometaphase and metaphase could still be clearly distinguished
(fig. 5D , F and G). In most cells with aberrant chromosome
morphology, the centrosome, labeled with an antibody for c-
tubulin protein [53], was located at the center of the chromatin
instead of the pole of cell (fig. S2). This abnormal localization of
the centrosome may explain the aberrant chromosome mor-
phology seen in mitotic cells after treatment with the JNK
inhibitor.
Figure 2. JNK3 is absent during mitosis of retinal progenitor cells. Representative confocal photomicrographs of immunohistochemistry for
JNK3 (red) and phospho-histone-H3 (green) in sections of retinal tissue maintained for 3 hours in vitro either in absence (A - CTR) or presence of taxol
(B - TAX). The sections were counterstained with DAPI (blue). Cells stained for JNK3 were found only in the ganglion cell layer (GCL), in the immature
inner nuclear layer and in a few cells in the NBL. Arrows indicate examples of JNK3 positive cells. Scale bar: 20 mm. CTR - control; TAX - taxol; GCL -
ganglion cell layer; NBL - neuroblastic layer.
doi:10.1371/journal.pone.0034483.g002
Figure 3. JNK1 and/or JNK2 are preferentially phosphorylated during mitosis of progenitor cells in developing retina. (A, B)
Representative confocal photomicrographs of immunohistochemistry for phospho-JNK1/2 (red) and phospho-histone-H3 (green) in sections of
retinal tissue maintained for 3 hours in vitro either in absence (A - CTR) or presence of taxol (B - TAX). The sections were counterstained with DAPI
(blue). Cells double stained for phospho-JNK1/2 and phospho-histone-H3 are indicated with arrows. Scale bar: 20 mm. Inset: higher magnification of
mitotic cells. (C) Representative western blot of phosphorylated JNK in total protein extracts of retinal explants maintained for 3 hours in vitro either
in absence (CTR) or presence of taxol (TAX). The upper blot was done with the antibody for phospho-JNK, the middle blot with an antibody for
phospho-histone-H3, and the lower blot with an antibody for b-actin as loading control. (D) Densitometric analysis of the western blot of phospho-
JNK. Data are means6S.E.M. from three independent experiments. CTR - control; TAX - taxol; GCL - ganglion cell layer; NBL - neuroblastic layer.
* P,0.05 versus CTR.
doi:10.1371/journal.pone.0034483.g003
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profiles (fig. 5G ), without any apparent change in the frequency of
prophase/prometaphases and metaphases (fig. 5G ). These data
suggest that the mitotic arrest induced by JNK inhibition occurs
either prior to, or at the metaphase-anaphase transition.
Discussion
This study addressed the behavior of JNK during the M-phase
of the cell cycle of retinal progenitor cells. The results showed that:
(a) In the retina of newborn rats (P1), JNK is phosphorylated
mainly during the early stages of mitosis; (b) The major isoforms
involved in this effect are JNK1 and/or JNK2. (c) Inhibition of
JNK induced cell cycle arrest in mitosis. (d) Treatment with the
JNK inhibitor decreased the number of cells in anaphase, but did
not alter the number of cells in either prophase/prometaphase or
metaphase. (e) Cells with aberrant chromatin morphology were
found after treatment with the JNK inhibitor.
Cells in the outer margin of retinal tissue, where mitosis occurs,
were double labeled for phospho-JNK and phospho-histone-H3,
and showed condensed chromatin typical of M-phase. The
phosphorylation of JNK in mitotic profiles was observed both in
retinas cultured in vitro and in freshly fixed retina (in situ), showing
that labeling in the explants was not due to the separation of the
retina from the pigment epithelium. We detected JNK phosphor-
ylation during mitosis of progenitor cells in the retina in situ at E21
and P1. The fact that JNK phosphorylation occurs during mitosis
only after E21 and that phospho-JNK staining was lighter at E21
when compared with P1, suggests that JNK phosphorylation may
be temporally regulated during retina development. We could not
detect JNK phosphorylation in M-phase of neural progenitor cells
in the cerebral cortex from P7 rats. This result suggests that JNK
activation during mitosis may not be a universal event and may be
unique in the retina. However, as the JNK phosphorylation
appears to be regulated during retinal development, similar
mechanisms may occur in the cerebral cortex. Therefore, a more
detailed analysis will be necessary to describe the occurrence of
phosphorylation of JNK in other areas of the CNS.
Treatment with taxol, that induces cell cycle arrest in mitosis,
increased the number of cells double labeled for phospho-JNK and
phospho-histone-H3. These data strongly suggest that JNK is
phosphorylated during mitosis of retinal progenitor cells. Our
immunohistochemical analysis points to JNK1 and/or JNK2 as
preferentially phosphorylated among the 3 isoforms of JNK in M-
Figure 4. JNK is phosphorylated preferentially during early stages of mitosis in retinal progenitor cells. (A–F) Representative confocal
photomicrographs of immunolabeling for phospho-JNK (red) in sections of retinal tissue maintained 3 hours in vitro showing mitotic cells. The
sections were counterstained with DAPI (blue). (A, B) Cells in prophase/prometaphase heavily labeled for phospho-JNK. (C, D) Cells in metaphase
heavily labeled for phospho-JNK. (E, F) Cells in anaphase either poorly labeled or unlabeled for phospho-JNK. Scale bar: 10 mm (G) Quantification of
phospho-JNK staining in different mitotic stages. Mitotic stages were classified according with chromatin morphology in prophase/prometaphase
(PRO), metaphase (META) or anaphase (ANA) and phospho-JNK staining were classified in heavily labeled, poorly labeled and unlabeled. The graph
represents pools of at least 250 mitotic cells in each experiment. Data are means6S.E.M. from three independent experiments.
doi:10.1371/journal.pone.0034483.g004
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taxol treatment, there is an increase in the phosphorylation status
only in the JNK2 isoforms. The small increase of only
approximately 24%, may be due to the fact that cells in M-phase
are only a small fraction of the retinal tissue and a consistent
increase of JNK phosphorylation with taxol was restricted to M-
phase cells, among a lighter staining of other cells. Thus the results
of the western blot may have been masked by phospho-JNK
staining in other cells. Our data suggest that JNK2 may be
preferentially activated during mitosis of retinal progenitor cells,
and therefore corroborate studies showing that JNK2 is involved
with cellular proliferation [20–24].
In our study, JNK were preferentially activated in early mitotic
stages. Recently, it was reported that JNK activity increases in
various cell lines during late G2 phase, and remains high at the
onset of mitosis, while in the final stages of mitosis JNK is
degraded via proteasome, mediated by the E3 ubiquitin ligase
APC/C [54], which is involved in the degradation of key proteins
of the cell cycle. Further experiments are needed to test whether
APC/C is also involved in the turnover of JNK in the developing
retinal tissue, wherein MAP kinase cascades are heavily dependent
on cell interactions [55].
Most studies of JNK activation in retinal tissue were done in the
context of neurodegeneration [56–60]. Our group has previously
shown that p38 kinase is also phosphorylated in M-phase of retinal
progenitor cells [49]. The current data add further evidence that
MAPKs are involved with cellular proliferation in developing
retinal tissue, in particular during M-phase. We found that an
inhibitor of JNK induced cell cycle arrest at the metaphase/
anaphase transition, accompanied by chromatin abnormalities in
the retina. In tumor cells, inhibition of JNK, either using a
pharmacological inhibitor or deletion of JNK1/2, induced cell
cycle arrest in M-phase and polyploidy [37,40]. Our group has
previously shown that inhibition of p38 kinase also increases the
number of M-phase cells in the mitotic stratum of retinal tissue
and causes chromatin abnormalities [49]. We found no evidence
of synergism between both inhibitors of JNK and p38 (data not
shown). Therefore, both kinases may work in a partially redundant
fashion to promote M-phase progression.
Among downstream targets of JNK, previous work has
identified Cdh1, Bcl-2, cytoskeletal proteins, histone-H3, Cdc25
and the transcription factor Sp1 during M-phase [54,61–66]. The
relevant substrates and the mechanisms of control of M-phase
progression by JNK in the retinal tissue remain, however, to be
determined. The abnormal localization of the centrosomal protein
c-tubulin, detected in most cells with aberrant chromosome
morphology, may be important for the M-phase arrest of the
proliferating cells.
It has been reported that inhibition of JNK2 causes defects in
central spindle formation and chromosome segregation during
anaphase in mammalian cells in culture [41]. Our data suggest
that JNK may be required for the separation or localization of
the centrosome in the cell poles, therefore controlling the
separation of chromatids at the outset of anaphase, and possibly
helping to prevent polyploidy. It has, indeed, been shown that
inhibition of JNK results in polyploidy and apoptosis of cultured
cell lines [37,40]. Thus, JNK may be important to maintain
genomic stability and prevent programmed cell death in
progenitor cells during retinal development. In conclusion, the
current study suggests a new role of JNK in the control of
progenitor cell proliferation, especially in mitosis, within retinal
tissue.
Figure 5. Inhibition of JNK induces mitotic arrest. (A, B) Representative confocal photomicrographs of immunohistochemistry for phospho-JNK
(red) and phospho-histone-H3 (green) in sections of retinal tissue maintained for 3 hours in vitro either in absence (A - CTR) or presence of SP600125
(B - SP). The sections were counterstained with DAPI (blue). Arrows indicate examples of phospho-histone-H3 positive cells. Scale bar: 20 mm. (C)
Numbers of phospho-histone-H3 stained cells per 100 mm of linear extent parallel to the retinal surface, along the mitotic stratum of retinal explants
maintained in vitro for 3 hours either in the absence (CTR - black column) or presence of SP600125 (SP - gray column). *** P,0.001 versus CTR. (D–F)
Representative confocal photomicrographs of mitotic cells immunolabeled for phospho-JNK (red) in sections of retinal tissue maintained for 3 hours
in vitro in the presence of SP600125. The sections were counterstained with DAPI (blue). Stages of mitosis are indicated as either prophase/
prometaphase (p) or metaphase (m), while arrows show aberrant chromosome morphology. Compare the disorganized chromatin with the profiles
shown in fig. 4. Scale bar: 5 mm. (G) Frequency of prophase/prometaphases (PRO), metaphases (META), anaphases (ANA) and aberrant profiles (ABE)
among all mitotic cells in the outer margin of retinal explants maintained in vitro for 3 hours either in the absence (CTR - black columns) or presence
of SP600125 (SP - gray columns). Data are means6S.E.M. pooled from at least 250 mitotic cells in each of six independent experiments. CTR - control;
SP - SP600125; NBL - neuroblastic layer. ** P,0.01 versus CTR.
doi:10.1371/journal.pone.0034483.g005
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Figure S1 JNK is phosphorylated during mitosis of
retinal progenitor cells in situ. Representative confocal
photomicrographs of immunohistochemistry for phospho-JNK
(red) and phospho-histone-H3 (green) in sections of freshly fixed
retinal tissue from rats at embryonic day 14 (A - E14), 18 (B - E18),
21 (C - E21) and at postnatal day 1 (D - P1) showing the NBL. The
sections were counterstained with DAPI (blue). Arrows indicate
examples of cells double stained for phospho-JNK and phospho-
histone-H3. NBL - neuroblastic layer. Scale bar: 20 mm.
(TIF)
Figure S2 Aberrant centrossomal localization in mitotic
cells following JNK inhibition. Representative confocal 3D
reconstruction photomicrographs of double staining for phospho-
JNK (red) and c-tubulin (green) in sections of retinal tissue
maintained in vitro for 3 hours in the presence of inhibitor of JNK,
showing mitotic cell. In cells with aberrant chromosome
morphology the centrosome is located in the center of the
chromatin instead of the pole of cell. Scale bar: 5 mm.
(TIF)
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